About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID 		Mtor
mechanistic target of rapamycin kinase
MGI:1928394
135 phenotypes from 14 alleles in 15 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background		 Annotated Term Reference
Mtorchino/Mtorchino
involves: C57BL/6JAnu 		decreased body size J:207898
decreased CD4-positive, alpha-beta T cell number J:207898
decreased splenocyte number J:207898
normal immune system phenotype J:207898
Mtorflat/Mtorflat
involves: BTBR/J * C57BL/6J 		abnormal diencephalon morphology J:53291
abnormal embryonic neuroepithelium morphology J:53291
abnormal forebrain morphology J:53291
abnormal midbrain morphology J:53291
absent embryonic telencephalon J:53291
decreased embryo size J:53291
embryonic growth retardation J:53291
embryonic lethality, complete penetrance J:53291
forebrain hypoplasia J:53291
incomplete embryo turning J:53291
Mtorflat/Mtorflat
Not Specified 		abnormal embryonic tissue morphology J:94381
absent embryonic telencephalon J:94381
decreased embryo size J:94381
embryonic growth arrest J:94381
embryonic growth retardation J:94381
incomplete embryo turning J:94381
MtorGt(OST92090)Lex/MtorGt(OST92090)Lex
involves: 129S5/SvEvBrd 		abnormal trophoblast giant cell morphology J:137592
absent inner cell mass proliferation J:137592
Mtortm1.1Clyn/Mtor+
involves: BALB/c * C57BL/6J 		abnormal muscle physiology J:162945
decreased circulating insulin-like growth factor I level J:162945
decreased lean body mass J:162945
decreased skeletal muscle weight J:162945
increased total body fat amount J:162945
Mtortm1.1Clyn/Mtortm1.1Clyn
involves: BALB/c * C57BL/6J 		embryonic lethality J:162945
Mtortm1.1Gcon/Mtortm1.1Gcon
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N 		abnormal autophagy J:163763
abnormal mitochondrial physiology J:163763
abnormal myocardial fiber morphology J:163763
abnormal myocardial fiber physiology J:163763
abnormal sarcomere morphology J:163763
abnormal translation J:163763
ascites J:163763
cardiac interstitial fibrosis J:163763
congestive heart failure J:163763
decreased cardiac muscle contractility J:163763
decreased heart left ventricle wall thickness J:163763
decreased heart ventricle muscle contractility J:163763
decreased myocardial fiber size J:163763
dilated cardiomyopathy J:163763
dilated mitochondrion J:163763
enlarged heart J:163763
increased cardiomyocyte apoptosis J:163763
increased heart atrium size J:163763
increased heart ventricle size J:163763
increased response of heart to induced stress J:163763
pleural effusion J:163763
premature death J:163763
thin interventricular septum J:163763
Mtortm1.1Koz/Mtor+
either: (involves: 129S4/SvJae) or (involves: 129S4/SvJae * C57BL/6) 		no abnormal phenotype detected J:94133
Mtortm1.1Koz/Mtortm1.1Koz
either: (involves: 129S4/SvJae) or (involves: 129S4/SvJae * C57BL/6) 		abnormal developmental patterning J:94133
abnormal embryonic tissue morphology J:94133
abnormal extraembryonic tissue morphology J:94133
abnormal trophoblast layer morphology J:94133
embryonic growth arrest J:94133
embryonic growth retardation J:94133
embryonic lethality during organogenesis, complete penetrance J:94133
inner cell mass degeneration J:94133
small ectoplacental cone J:94133
Mtortm1.1Lgm/Mtortm1.1Lgm
involves: 129S1/Sv * C57BL/6 		normal growth/size/body region phenotype J:168600
normal immune system phenotype J:168600
Mtortm1.1Seq/Mtortm1.2Seq
Tg(Nphs2-cre)1Seq/?
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL 		abnormal cell morphology J:184667
abnormal podocyte morphology J:184667
abnormal renal glomerular capsule morphology J:184667
abnormal renal glomerulus morphology J:184667
abnormal renal tubule morphology J:184667
abnormal urine homeostasis J:184667
increased glomerular capsule space J:184667
podocyte foot process effacement J:184667
postnatal growth retardation J:184667
Mtortm1.2Koz/Mtortm1.2Koz
Tg(ACTA1-cre)79Jme/?
involves: 129S4/SvJae * C57BL/6J * SJL 		abnormal diaphragm morphology J:162918
abnormal gastrocnemius morphology J:162918
abnormal limb muscle morphology J:162918
abnormal limb posture J:162918
abnormal muscle contractility J:162918
abnormal muscle morphology J:162918
abnormal muscle physiology J:162918
abnormal muscle relaxation J:162918
abnormal oxygen consumption J:162918
abnormal skeletal muscle fiber morphology J:162918
abnormal soleus morphology J:162918
abnormal tibialis anterior morphology J:162918
centrally nucleated skeletal muscle fibers J:162918
decreased body weight J:162918
decreased circulating glucose level J:162918
decreased mitochondrial number J:162918
decreased oxygen consumption J:162918
decreased respiration J:162918
increased muscle fatigability J:162918
increased skeletal muscle glycogen level J:162918
kyphosis J:162918
postnatal growth retardation J:162918
premature death J:162918
skeletal muscle degeneration J:162918
skeletal muscle fiber degeneration J:162918
Mtortm1.2Koz/Mtortm1.2Koz
Tg(Cd4-cre)1Cwi/0
involves: 129S4/SvJae * C57BL/6 * DBA/2 		abnormal T cell differentiation J:150108
abnormal T cell subpopulation ratio J:150108
abnormal thymus cell ratio J:150108
decreased interferon-gamma secretion J:150108
decreased interleukin-2 secretion J:150108
decreased interleukin-17 secretion J:150108
decreased T cell proliferation J:150108
decreased tumor necrosis factor secretion J:150108
increased regulatory T cell number J:150108
Mtortm1.2Seq/Mtortm1.2Seq
involves: C57BL/6 * SJL 		prenatal lethality, complete penetrance J:184667
Mtortm1a(EUCOMM)Wtsi/Mtor+
C57BL/6N-Mtortm1a(EUCOMM)Wtsi/Wtsi 		decreased blood urea nitrogen level J:175295
decreased circulating LDL cholesterol level J:175295
increased circulating LDL cholesterol level J:175295
increased mean corpuscular hemoglobin J:175295
Mtortm1a(EUCOMM)Wtsi/Mtortm1a(EUCOMM)Wtsi
C57BL/6N-Mtortm1a(EUCOMM)Wtsi/Wtsi 		preweaning lethality, complete penetrance J:211773
Mtortm1Koz/Mtortm1Koz
Cnptm1(cre)Kan/Cnp+
involves: 129S4/SvJae * C57BL/6 		abnormal axolemma morphology J:181341
abnormal axon morphology J:181341
abnormal internode morphology J:181341
abnormal motor coordination/balance J:181341
abnormal myelin sheath morphology J:181341
abnormal myelination J:181341
abnormal Schwann cell morphology J:181341
decreased nerve conduction velocity J:181341
decreased Schwann cell number J:181341
Mtortm1Lgm/Mtortm1Lgm
involves: 129S1/Sv * C57BL/6 		abnormal B cell physiology J:168600
abnormal humoral immune response J:168600
abnormal T cell morphology J:168600
abnormal T cell physiology J:168600
decreased B cell number J:168600
decreased B cell proliferation J:168600
decreased body size J:168600
decreased body weight J:168600
decreased double-positive T cell number J:168600
decreased follicular B cell number J:168600
decreased IgG level J:168600
decreased IgM level J:168600
decreased marginal zone B cell number J:168600
decreased monocyte cell number J:168600
decreased neutrophil cell number J:168600
decreased plasma cell number J:168600
decreased splenocyte apoptosis J:168600
decreased splenocyte proliferation J:168600
decreased thymocyte number J:168600
decreased transitional stage T1 B cell number J:168600
impaired B cell migration J:168600
increased CD4-positive, alpha-beta T cell number J:168600
increased CD8-positive, alpha-beta T cell number J:168600
preweaning lethality, incomplete penetrance J:168600
small spleen J:168600
Mtortm1Yam/Mtortm1Yam
involves: 129S4/SvJae 		abnormal gastrulation J:92252
abnormal trophoblast layer morphology J:92252
absent inner cell mass proliferation J:92252
embryonic lethality between implantation and somite formation, complete penetrance J:92252
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
11/12/2024
MGI 6.24 		The Jackson Laboratory